Global Advanced Infusion Systems Market Insights, Trends, Outlook and Opportunity Analysis, 2018-2023

Global Advanced Infusion Systems Market was worth $XX million in 2018 and estimated to reach $XX million by the end of 2023 with a CAGR of XX%. Infusion systems are medical instruments and disposables, which are used to distribute fluids or administer drugs in the form of solution to the patient’s circulatory system in a precise, controlled and systematic manner.

There are various methods to administer a drug into the patient’s system, of which, the most used mode is through intravenous, although arterial, subcutaneous and epidural infusion are more favorable. This instrument was widely used for medication purposes but because of high mortality rates associated with it, advanced infusion systems were developed.

Request a Sample of this Report@ http://www.orbisresearch.com/contacts/request-sample/2321489

Advanced Infusion Systems are a class of drug delivery devices that have found extensive acceptance and usage across various areas. Their popularity is mainly because of their dependable, ergonomic design and easy-to-use features. These pumps have bolstered their position in a wide range of application areas including diabetes, oncology, enteral feeding pain management, and general infusion. Features like visual monitoring, easy start up, mobility of system, steady and continuous infusion of multiple drugs at the same time, patient safety some of the major factors that are furthering the growth of the potential market of advanced infusion systems over conventional ones.

The growth in this market is largely driven by the increasing incidence of cancer, diabetes and chronic diseases owing to the rising geriatric population. Increasing use of infusion products in homecare with encouraging reimbursements has hugely boosted this market. Immensely developed technology in infusion systems which eliminates user-related risks, safety, therapeutic effectiveness, higher bioavailability, increase in healthcare spending are also some other factors that propel the growth of the market. However, to operate these advanced infusion systems, extensive training is required. If the training is not good enough, it can lead to increased mortality rate, which is restraining the growth of this market to some extent. The presence of strict regulations for product approval and possible medication errors associated with infusion pump may restrain the growth of the market during the forecast period.

Global advanced infusion systems market is segmented based on type of application, type of product and end-users. Applications are segmented into Clinical Nutrition, Chemotherapy, Pain Management, Diabetes and Asthma Treatment. Product type is segmented into Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System and Implantable Infusion System. End-users has been further segmented as Diagnostic Centers, Hospitals and Ambulatory Surgical Centers. On the basis of geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America commands the largest regional segment of the global advanced infusion systems market. In 2015, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific,

Latin America, and the Middle East and Africa. This is mainly because of the high adoption of ambulatory pumps in the management of chronic diseases; high prevalence of rising penetration of advanced infusion systems; chronic diseases; and well-established healthcare infrastructure in the region. Asia-Pacific countries, particularly China and India) are expected to offer substantial growth opportunities for market players in the forecast period owing due to the huge patient population, increasing incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and increasing disposable income.

Hospira, Inc., is a market leader in infusion technologies globally. The major players in these markets are AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.

Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.

An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

To make an enquiry on report@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2321489

Some Point from Table of Content:

1.Introduction

2.Research Methodology

3.Overview

4.Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

5.Market Segmentation

6.Geographical Analysis

7.Strategic Analysis

8.Market Leaders’ Analysis

8.1 Hospira, Inc.

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 AngioDynamics, Inc.

8.3 Medtronic, Inc.

8.4 Terumo Corporation

8.5 Johnson & Johnson

8.6 CareFusion Corporation

8.7 Animas Corporation

8.8 Baxter International Inc.

8.9 B. Braun Melsungen AG

8.10 I-Flow Corporation

8.11 F. Hoffmann-La Roche Ltd

9.Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations and Joint Ventures

9.4 New Product Launches

10.Market Outlook and Investment Opportunities

Appendix

a) List of Tables

b) List of Figures

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No: +1 (214) 884-6817; +912064101019

Email ID: [email protected]

FacebookTwitterGoogle+Share